Additionally, CEACAM6 was negatively correlated with EMT in pancreatic carcinomas [19] and CEACAM6 suppression could increase E-cadherin promoter activity in colorectal cancer [20]. The gene discussed is CEACAM6; the disease is colorectal cancer.